T-DM1 Storms All Stages of HER2+ Breast CancerT-DM1 Storms All Stages of HER2+ Breast Cancer

Dr. Lidia Schapira discusses the TH3RESA trial and how T-DM1 is strongly active across all stages of HER2-positive breast cancer, offering yet another effective option with low toxicity. Medscape Oncology

Source: Medscape Hematology-Oncology Headlines - July 11, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology Viewpoint Source Type: news